Bless et al. reported that erioflorin inhibits the activity of tumor-associated transcription factors regulated by Pdcd4 and IκBα, such as AP-1 and NF-κB, which alters cell cycle progression and suppresses proliferation of various cell lines [25]. The gene discussed is PDCD4; the disease is neoplasm.